[SaneVax: More than half of the 3.28 million citizens of Japan injected with Gardasil or Cervarix reported adverse reactions. The Ministry of Health, Industry and Welfare rescinded their recommendation for both vaccines pending the outcome of investigations into the cause of these new medical conditions. ...
READ MOREHPV Vaccine Policy: At Odds With Evidence-Based Medicine?
Roxanne Nelson/From Medscape Medical News January 31, 2012 — Is the policy for the human papillomavirus (HPV) vaccine at odds with evidence-based medicine? Yes, according to an essay published online December 22, 2011, in the Annals of Medicine. Canadian researchers Lucija Tomljenovic, PhD, and Christopher ...
READ MOREHPV Vaccine Injury Victims Deserve Help, Not Media Abuse
To: Opinion Editor, Minneapolis Star Tribune From: Nancy Hokkanen, Vaccine Safety Council of Minnesota Date: Thursday, September 22, 2011 Re: Commentary (604 words) Whatever one’s opinion of Rep. Michele Bachmann, she spotlighted a dirty little secret: the silent epidemic of vaccine injury, and its ongoing ...
READ MOREA License to Kill? Part 1: How A Public-Private Partnership Made the Government Merck’s Gardasil Partner
By Mark Blaxill “Perhaps no other recent product on the market demonstrates successful health care technology transfer better than the human papillomavirus (HPV) vaccine, Gardasil, produced by Merck & Co. and approved by the FDA in June 2006,” proclaimed a recent National Institutes of Health ...
READ MOREA License to Kill? Part 2: Who Guards Gardasil’s Guardians?
By Mark Blaxill In the first part of this report (HERE), Age of Autism identified a pattern of conflict of interest at the Department of Health and Human Services (DHHS) involving Merck’s Gardasil vaccine. Researchers at the National Cancer Institute (NCI) invented critical technology for ...
READ MOREA License to Kill? Part 3: After Gardasil’s Launch, More Victims, More Bad Safety Analysis and a Revolving Door Culture
By Mark Blaxill In parts 1 (HERE) and 2 (HERE) of this series, Age of Autism identified a disturbing pattern of conflicts within the Department of Health and Human Services (DHHS) regarding Merck’s Gardasil vaccine. In an unprecedented “public-private partnership,” researchers at the National Institutes ...
READ MORE